- Volume 26 Issue 5
DOI QR Code
Structural Characteristics and Anti-inflammatory Activities of Chemically Sulfated-hyaluronic Acid from Streptococcus dysgalactiae
Streptococcus dysgalactiae로부터 분리된 히알루론산과 황화된 유도체의 구조와 항염증 활성
- Hong, Chang-Il (Department of Life Science and Biotechnology, Soonchunhyang University) ;
- Jung, Eui-Gil (Department of Life Science and Biotechnology, Soonchunhyang University) ;
- Han, Kook-Il (Department of Life Science and Biotechnology, Soonchunhyang University) ;
- Kim, Yong Hyun (BMI Korea Co. Ltd.) ;
- Lee, Sung Hee (BMI Korea Co. Ltd.) ;
- Lee, Hong Sub (Laboratory of Microbiology, Il-dong Pharmaceutical Co. Ltd.) ;
- Han, Man-Deuk (Department of Life Science and Biotechnology, Soonchunhyang University)
- 홍창일 (순천향대학교 생명시스템학과) ;
- 정의길 (순천향대학교 생명시스템학과) ;
- 한국일 (순천향대학교 생명시스템학과) ;
- 김용현 ((주)한국비엠아이) ;
- 이성희 ((주)한국비엠아이) ;
- 이홍섭 (일동제약(주)) ;
- 한만덕 (순천향대학교 생명시스템학과)
- Received : 2016.04.13
- Accepted : 2016.04.22
- Published : 2016.05.30
Hyaluronic acid (HA) is an important macromolecule in medical and pharmaceutical fields. HA is a natural and linear polymer composed of repeating disaccharide units of β-1, 3-N-acetyl glucosamine and β-1, 4-glucuronic acid. This work aimed to confirm the structural characteristics and anti-inflammatory activities of HA and its chemically sulfated-HA. HA was produced from a fed-batch fermentation process using Streptococcus dysgalactiae in a 5 l bioreactor. HA was isolated water-soluble form (HA-WS) and water-insoluble form (HA-WI) from culture medium, and was obtained chemically sulfated-derivative (S-HA) that resulted in a 90% yield from HA-WI. The structural features of the sulfated- HA (S-HA) were investigated by FT-IR and 1H-NMR spectroscopy. The FT-IR and NMR patterns revealed the similarity in both the FTIR spectrum as well as NMR spectrum of both reference standard and purified HA from S. dysgalactiae. The anti-inflammatory activities of HA and S-HA were examined on LPS-induced RAW 264.7 cells. S-HA was significantly inhibited production of pro-inflammatory mediators such as nitric oxide (NO) and PGE2 and the gene levels of iNOS and COX-2, which are responsible for the production of NO and PGE2, respectively. Furthermore, S-HA also suppressed the overproduction of pro-inflammatory cytokine TNF-α (<80 pg/ml) and IL-6 (<100 pg/ml) compared to that of HA-WI. The present study clearly demonstrates that HA-S exhibits anti-inflammatory activities in RAW 264.7 macrophage cells.
Anti-inflammatory activity;hyaluronic acid;proinflammatory mediators;Streptococcus dysgalactiae;sulfated-hyaluronic acid
- Alkrad, J. A., Mrestani, Y., Stroehl, D., Wartewig, S. and Neubert, R. 2003. Characterization of enzymatically digested hyaluronic acid using NMR, Raman, IR, and UV-Vis spectroscopes. J. Pharmaceut. Biomed. 31, 545-550. https://doi.org/10.1016/S0731-7085(02)00682-9
- Allison, D. D. and Grande-Allen, K. J. 2006. Review. Hyaluronan: a powerful tissue engineering tool. J. Tissue Eng. 12, 2131-2140. https://doi.org/10.1089/ten.2006.12.2131
- Bernanke, D. H. and Orkin, R. W. 1984. Hyaluronidase activity in embryonic chick heart muscle and cushion tissues and cells. J. Dev. Biol. 106, 351-359. https://doi.org/10.1016/0012-1606(84)90233-1
- Boeriu, C. G., Springer, J., Kooy, F. K., van den Broek, L. A. M. and Eggink, G. 2013. Production methods for hyaluronan. J. Carbohydr. Chem. 2013, 14.
- Burdick, J. A. and Prestwich, G. D. 2011. Hyaluronic acid hydrogels for biomedical applications. J. Adv. Mater. 23, 41-56. https://doi.org/10.1002/adma.201003963
- Celec, P. 2004. Nuclear factor kappa B-molecular biomedicine: the next generation. Biomed. Pharmacother. 58, 365-371. https://doi.org/10.1016/j.biopha.2003.12.015
- Choi, C. Y., Park, J. K., Kim, W. S., Jang, M. K. and Nah, J. W. 2011. Preparation and characterization of deoxycholic acid-grafted hyaluronic acid as a drug carrier. Polym. Korea. 35, 119-123.
- Condie, R. C. and Prestwich, G. D. 2010. Engineering clinically useful hyaluronan matrices. In: Vernon, B. (ed.), Injectable Biomaterials: Science and application. Woodhead Publishing Limited: London, United Kingdom.
- Duerksen-Hughes, P. J., Day, D. B., Laster, S. M., Zachariades, N. A., Aquino, L. and Gooding, L. R. 1992. Both tumor necrosis factor and nitric oxide participate in lysis of simian virus 40-transformed cells by activated macrophages. J. Immunol. 149, 2114-2122.
- Fraser, J. R., Laurent, T. C. and Laurent, U. B., 1997. Hyaluronan: its nature, distribution, functions and turnover. J. Intern. Med. 242, 27-33. https://doi.org/10.1046/j.1365-2796.1997.00170.x
- Girish, K. S. and Kemparaju, K. 2007. The magic glue hyaluronan and its eraser hyaluronidase a biological overview. J. Life Sci. 80, 1921-1943. https://doi.org/10.1016/j.lfs.2007.02.037
- Han, M. D., Han, Y. S., Hyun, S. H. and Shin, H. W. 2008. Solubilization of water-insoluble beta-glucan isolated from Ganoderma lucidum. J. Environ. Biol. 29, 237-42.
- Hiro, D., Ito, A., Matsuta, K. and Mori, Y. 1986. Hyaluronic acid is an endogenous inducer of interleukin-l production by human monocytes and rabbit macrophages. Biochem. Biophys. Res. Commun. 140, 715-722. https://doi.org/10.1016/0006-291X(86)90790-4
- Hwang, S. G., Yang, A. N., Kim, S. J., Kim, M. K., Oh, H. J., Lee J. D., Lee, E. J., Nam, K. W. and Han, M. D. 2014. Screening of hyaluronidase inhibitor in Korean medicinal plants. J. Life Sci. 24, 498-504. https://doi.org/10.5352/JLS.2014.24.5.498
- Kuo, J. W. 2006. Practical aspects of hyaluronan based medical products. pp. 217. CRC Press/Taylor & Francis Group: Boca Raton, FL, United States.
- Kuo, J. W. and Prestwich, G. D. 2010. Hyaluronic acid. pp. 239-259 In: Ducheyne, P., Healy, K., Hutmacher, D., Kirkpatrick, J. (eds), Comprehensive biomaterials. Elsevier Publishers: Amsterdam, Netherlands.
- Laurent, T. C. and Fraser, J. R. 1986. The properties and turnover of hyaluronan. Ciba Found. Symp. 124, 9-29.
- Laurent, T. C. and Fraser, J. R. 1992. Hyaluronan. FASEB J. 6, 2397-2404.
- Lim, H. R. and Shin, S. W. 2010. Effects of the essential oil components from Ligusticum chuanxiong on proinflammatory mediators of RAW264.7 macrophage cells. Nat. Prod. Sci. 16, 259-264.
- Liu, L., Liu, Y., Li, J., Du, G. and Chen, J. 2011. Microbial production of hyaluronic acid: current state, challenges, and perspectives. Microb. Cell Fact. 10, 99. https://doi.org/10.1186/1475-2859-10-99
- Locksley, R. M., Killeen, N. and Lenardo, M. J. 2001. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104, 487-501. https://doi.org/10.1016/S0092-8674(01)00237-9
- Masters, S. L., Simon, A. Aksentijevich, I. and Kastner, D. L. 2009. Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease. Annu. Rev. Immunol. 27, 621-668. https://doi.org/10.1146/annurev.immunol.25.022106.141627
- Mosmann, T. 1985. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. J. Immunol. Methods 65, 55-63.
- Park, H. S., Kim, A. R. and Noh, I. 2013. Physical and biological evaluations of cross-linked hyaluronic acid film. Biomater. Res. 17, 153-159.
- Park, S. G., Jegal, K. H., Jung, J. Y., Back, Y. D. Byun, S. H., Kim, Y. W., Cho, I. J., Park, S. M. and Kim, S. C. 2014. Leonuri Fructus ameliorates acute inflammation via the inhibition of NF-κB-mediated nitric oxide and pro-inflammatory cytokine production. Kor. J. Orient. Physiol. Pathol. 28,178-185.
- Prestwich, G. D. 2007. Simplifying the extracellular matrix for 3-D cell culture and tissue engineering: a pragmatic approach. J. Cell. Biochem. 101, 1370-1383. https://doi.org/10.1002/jcb.21386
- Prestwich, G. D. and Kuo, J. W. 2008. Chemically-modified HA for therapy and regenerative medicine. Curr. Pharm. Biotechnol. 9, 242-245. https://doi.org/10.2174/138920108785161523
- Ritchlin, C. T., Haas-Smith, S. A., Li, P., Hicks, D. G. and Schwarz, E. M. 2003. Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis. J. Clin. Invest. 111, 821-831. https://doi.org/10.1172/JCI200316069
- Ruggiero, S. L., Bertolami, C. N., Bronson, R. E. and Damiani, P. J. 1987. Hyaluronidase activity of rabbit skin wound granulation tissue fibroblasts. J. Dent. Res. 66, 1283-1287. https://doi.org/10.1177/00220345870660071301
- Shiedlin, A., Bigelow, R., Christopher, W. Arbabi S, Yang, L., Maier, R. V., Wainwright, N., Childs, A. and Miller, R. J. 2004. Evaluation of hyaluronan from different sources: streptococcus zooepidemicus, rooster comb, bovine vitreous, and human umbilical cord. Biomacromolecules 5, 2122-2127. https://doi.org/10.1021/bm0498427
- Shu, X. Z. and Prestwich, G. D. 2001. Therapeutic Biomaterials from Chemically Modified Hyaluronan. pp. 475-504. In: Hales, C. A. (ed.), Chemistry and Biology of Hyaluronan. Woodhead Publishing Limited: London, United Kingdom.
- Toole, B. P. 2001. Hyaluronan in morphogenesis. Semin. Cell Dev. Biol. 12, 79-87. https://doi.org/10.1006/scdb.2000.0244
- Toole, B. P. 2004. Hyaluronan: from extracellular glue to pericellular cue. Nat. Rev. Cancer 4, 528-539. https://doi.org/10.1038/nrc1391
- Wang, S., Chen, Y., He, D., Yang, Y., Chen, J. and Wang, X. 2007. Inhibition of vascular smooth muscle cell proliferation by serum from rats treated orally with Gastrodia and Uncaria decoction, a traditional Chinese formulation. J. Ethnopharmacol. 114, 458-462. https://doi.org/10.1016/j.jep.2007.08.039
- Weiss, C. 1998. Viscoseparation and viscoprotection as therapeutic modalities in the musculoskeletal system. pp. 255-266. In: Laurent, T. C. (ed.) The chemistry, biology and medical applications of hyaluronan and its derivatives. Woodhead Publishing Limited: London, The United Kingdom.
- West, D. C., Hampson, I. N., Arnold, F. and Kumar, S. 1985. Angiogenesis induced by degradation products of hyaluronic acid. Science 228, 1324-1328. https://doi.org/10.1126/science.2408340
- Yun, H. Y., Dawson, V. L. and Dawson, T. M. 1996. Neurobiology of nitric oxide. Crit. Rev. Neurobiol. 10, 291-316. https://doi.org/10.1615/CritRevNeurobiol.v10.i3-4.20